BODIPY-Based Molecules for Biomedical Applications

Biomolecules. 2023 Nov 30;13(12):1723. doi: 10.3390/biom13121723.

Abstract

BODIPY (4,4-difluoro-4-bora-3a,4a-diaza-s-indacene) derivatives have attracted attention as probes in applications like imaging and sensing due to their unique properties like (1) strong absorption and emission in the visible and near-infrared regions of the electromagnetic spectrum, (2) strong fluorescence and (3) supreme photostability. They have also been employed in areas like photodynamic therapy. Over the last decade, BODIPY-based molecules have even emerged as candidates for cancer treatments. Cancer remains a significant health issue world-wide, necessitating a continuing search for novel therapeutic options. BODIPY is a flexible fluorophore with distinct photophysical characteristics and is a fascinating drug development platform. This review provides a comprehensive overview of the most recent breakthroughs in BODIPY-based small molecules for cancer or disease detection and therapy, including their functional potential.

Keywords: BODIPY; BODIPY dyes; BODIPY-based functional materials for medical use; fluorescent probe.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Boron Compounds* / therapeutic use
  • Fluorescence
  • Fluorescent Dyes
  • Photochemotherapy*

Substances

  • 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
  • Boron Compounds
  • Fluorescent Dyes

Grants and funding

This research was funded by SERB, India under the grant number SERB_SRG/2023/000841.